An-Najah Staff

 Crohn’s disease is a chronic inflammatory pathology potentially affecting the entire GI tract. The terminal ileum and proximal colon are the parts of the intestine that are mostly affected. MRI both of the small and large bowel has become an established method for the assessment of inflammatory bowel diseases [1, 2]. A good distension of the intestine is crucial for bowel imaging. Regarding the colon it can be easily accomplished by the administration of a rectal enema consisting of liquid or gasiform contrast agents. For the visualization of the small bowel, several oral contrast agents have been introduced. Aim of the present study was to evaluate the practicability of combining an oral and rectal contrast agent for MR imaging in patients with Crohn´s disease and to assess the accuracy of the method for the detection of inflammatory processes.